Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
AbbVie
AddedMar 19, 2024
UpdatedJul 9, 2026
AbbVie

AbbVie

Public

Innovative pharmaceuticals for various health conditions.

HQ
North Chicago, IL, US
Founded
2013
Overview
Compare
Fundraising
Employees

AbbVie Inc., founded on April 10, 2012, is a biopharmaceutical company headquartered in North Chicago, Illinois. The company's core mission is to discover, develop, manufacture, and sell innovative pharmaceuticals that address complex health conditions. AbbVie's product portfolio includes Humira for autoimmune diseases, Skyrizi for plaque psoriasis and Crohn's disease, Rinvoq for rheumatoid arthritis and ulcerative colitis, and Imbruvica for cancer treatments. The company serves over 170 countries worldwide, focusing on improving patient outcomes through advanced medical therapies.

Key figures at AbbVie include Richard A. Gonzalez, the chairman and CEO, and Robert Michael, the president and COO. The company is publicly traded on the NYSE under the ticker ABBV and is a component of both the S&P 100 and S&P 500 indices. AbbVie has achieved significant milestones, including the widespread adoption of its flagship drug Humira, which has become one of the best-selling pharmaceuticals globally. The company's impact is profound, contributing to advancements in treating various chronic and life-threatening conditions, thereby enhancing the quality of life for millions of patients worldwide.

AbbVie - Similar Companies

Bristol Myers Squibb logo

Bristol Myers Squibb

bms.com

Genentech logo

Genentech

gene.com

Eli Lilly and Company logo

Eli Lilly and Company

lilly.com

Gilead Sciences logo

Gilead Sciences

gilead.com

AstraZeneca logo

AstraZeneca

astrazeneca.com

Bayer Pharmaceuticals logo

Bayer Pharmaceuticals

bayer.com

Viatris logo

Viatris

viatris.com

Biogen logo

Biogen

biogen.com

Kyntra Bio logo

Kyntra Bio

fibrogen.com

Regeneron Ph logo

Regeneron Ph

regeneron.com

Sanofi logo

Sanofi

sanofi.com

GSK logo

GSK

gsk.com

Merck & CO INC Cedear EAC 5 RE logo

Merck & CO INC Cedear EAC 5 RE

merck.com

Xeris Biopharma Holdings logo

Xeris Biopharma Holdings

Bayer logo

Bayer

bayer.com

AbbVie - Quick Facts

Who are AbbVie's competitors?

Companies similar to AbbVie include Bristol Myers Squibb, Genentech, Eli Lilly and Company and Gilead Sciences.

When was AbbVie founded?

AbbVie was founded in 2013.

Where is AbbVie's headquarters located?

AbbVie's headquarters is located in North Chicago, IL, US.

When was AbbVie's last funding round?

AbbVie's most recent funding round was for $250k (USD) in March 2023.

How much has AbbVie raised to-date?

As of Mar 8, 2023, AbbVie has raised a total of $250k (USD).

How many employees does AbbVie have?

AbbVie has 50,000 employees as of Feb 6, 2024.

AbbVie - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Biotech
  • Healthcare
  • Healthtech
  • Pharmaceutical
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 17 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 4649Wholesale of other household goods
  • 7210Research and experimental development on natural sciences and engineering